FA patients have a predisposition to liver tumors and FANCD2–/– mice develop hepatic adenoma and HCC, supporting a role that disrupting the FA pathway and thus the repair of ICLs promotes HCC induction (51–55). The gene discussed is FANCD2; the disease is hepatocellular carcinoma.